Nasdaq GlobeNewswire

HAProxy Technologies Announces Improvements to Performance, Management, and Security for Enterprises

Del

HAProxy Enterprise Edition 1.8r1 Adds HTTP/2, Dynamic Scaling, WAF, and Other Key Enterprise Features

BOSTON, May 02, 2018 (GLOBE NEWSWIRE) -- HAProxy Technologies, the company behind the world's fastest and most widely used software load balancer, is announcing the release of HAProxy  Enterprise Edition 1.8r1. HAProxy Enterprise Edition 1.8r1 is built on top of the monumental stable release of HAProxy 1.8 with additional enhancements that help enterprises manage and secure modern application environments across the full spectrum of today's threats.

HAProxy Enterprise Edition 1.8r1 contains a number of powerful improvements in performance and application acceleration such as support for HTTP/2, Multithreading, and Small Object Caching. There are also significant improvements in dynamic capabilities for cloud and microservices environments including Hitless Reloads, DNS for Service Discovery, Server Templates, and improved Runtime API functionality.

"This is the biggest and possibly most anticipated release of HAProxy Enterprise Edition we have ever had," said Willy Tarreau, CTO HAProxy Technologies. "I'm very proud of the whole HAProxy Technologies R&D team as well as the community contributors for their hard work in advancing HAProxy in multiple key areas including fast and secure edge and microservices delivery, while maintaining the proven reliability that it is known for."

HAProxy Enterprise Edition 1.8r1 ships with an enterprise suite which contains administration and security-focused add-ons that have the same level of high performance that users expect from HAProxy. The latest additions include a new Web Application Firewall, Stick Table Aggregator with real time, cluster-wide tracking for improved DDoS attack and bot protection, direct integration with Google reCAPTCHA, Single Sign On (SSO) support, and significant improvements to the Real Time Dashboard.

"As the company behind the world's fastest and most widely used software load balancer, we have been trusted by millions of websites to continually deliver highly secure and reliable products," said Dujko Radovnikovic, CEO HAProxy Technologies. "Our latest release strengthens this trust by providing a powerful set of new features to manage and secure modern applications while maintaining our best-in-class performance and reliability."

"We initially chose HAProxy Enterprise Edition over other software load balancers due to its performance and reliability. Since then we've worked closely with the HAProxy Technologies team to provide feedback and leverage their support. We are very excited to see the 1.8r1 release which not only includes many useful capabilities, but also incorporates many of our own feature requests," said Scott Bruce, Director of Application Architecture, dataxu.

HAProxy 1.8 and HAProxy Enterprise Edition 1.8r1 Key Enhancements:

  • HTTP/2 Support - Support for clients to communicate with the load balancer via the HTTP/2 protocol.

  • Multithreading - Splits processing across multiple threads while sharing the same memory space.

  • HTTP Small Object Caching - Caches small objects in memory.

  • Hitless Reloads - Reloads of HAProxy do not lose any connections for upgrades or changes to the configuration.

  • DNS for Service Discovery - Dynamically scales the number of backend servers by querying the service registry over DNS. Maintains the IP address, port, and weight of the servers within HAProxy.

  • Server Templates - Enables the provisioning of multiple backend servers with a single server line to be filled in during runtime.

  • Improved Runtime API - Gives the ability to pull statistics and information from HAProxy or to dynamically configure it during runtime.

Exclusive HAProxy Enterprise Edition 1.8r1 Key Enhancements:

  • WAF Module - A high-performance Web Application Firewall which supports both whitelist based and blacklist based rulesets, ensuring a very high level of protection for even the most insecure web applications.

  • Stick Table Aggregator - Combines values from stick tables across multiple processes or servers which allows for real time cluster-wide tracking of any characteristic of a request.

  • reCAPTCHA Module - Enables presenting anomalous clients with Google reCAPTCHA v2 challenges which can protect websites from bots and other types of automated threats while letting real users pass through with ease.

  • SSO Module - Enables the implementation of SSO (Single Sign On) on a Microsoft Active Directory domain.

  • Real Time Dashboard - Provides management capabilities and an aggregated view of service activity and status which updates and graphs in real time, with visual alerting when values reach defined thresholds.

For more information on everything new in HAProxy Enterprise Edition 1.8r1, you can watch the on-demand webinar at What's New in HAProxy Enterprise Edition 1.8r1

About HAProxy Enterprise Edition

HAProxy Enterprise Edition is an enterprise-class version of HAProxy that includes a robust and cutting-edge code base, enterprise suite of add-ons, expert support, and professional services. At its core, it incorporates feature backports from the HAProxy development branch for customers who require immediate access to the latest functionality in a hardened version of code.

About HAProxy Technologies

HAProxy Technologies is the company behind HAProxy, the world's fastest and most widely used software load balancer. High-profile websites including Booking.com, GitHub, Reddit, StackOverflow, Tumblr, Vimeo and Yelp choose HAProxy to deliver websites and applications with high availability, performance, and security at any scale. Trusted by leading cloud providers such as Amazon Web Services, Rackspace, Red Hat OpenShift, and OpenStack, HAProxy sets the standard for superior application delivery. HAProxy Technologies is headquartered in Waltham, MA, with offices in France and Croatia. For more information on HAProxy, support, and enterprise solutions, visit: www.haproxy.com. You can also follow @HAProxy on Twitter or visit us on LinkedIn and Facebook for more information about HAProxy.

Media Contact

Company Name: HAProxy Technologies
Email Address: press@haproxy.com Website: www.haproxy.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: HAProxy Technologies via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Checkpoint Therapeutics Announces Presentation of Updated Data from Phase 1/2 Trial of EGFR Inhibitor CK-10125.9.2018 14:00Pressemelding

Data were featured in an oral presentation at the IASLC 19th World Conference on Lung Cancer Phase 3 trial in treatment-naïve EGFR mutation-positive NSCLC patients targeted to commence in 2019 NEW YORK, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced that positive preliminary safety and efficacy data from an ongoing Phase 1/2 clinical trial of CK-101 were presented yesterday in an oral presentation at the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer in Toronto. The oral presentation included further details on, and updates from, the dataset announced previously. CK-101 is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) being evaluated in advanced non

SpeeDx Begins Multisite U.S. Clinical Trials of ResistancePlus® MG Test25.9.2018 14:00Pressemelding

Test supports international guidelines for treating antibiotic resistant STI SYDNEY, Australia, Sept. 25, 2018 (GLOBE NEWSWIRE) -- SpeeDx Pty. Ltd. today announced the start of patient testing in their multisite U.S.-based clinical trials for ResistancePlus® MG (not available for sale in the U.S.). The molecular diagnostic test detects the sexually transmitted infection (STI) Mycoplasma genitalium, also known as Mgen or MG, along with genetic markers linked to antibiotic resistance. In recent years, Mgen prevalence has increased globally and developed high rates of resistance to the common antibiotic treatment, azithromycin. "This test is an exciting new development that will increase the precision of patient care for patients impacted by Mycoplasma genitalium - a common sexually transmitted infection with limited treatment options,” notes Dr Maria Trent, Professor of Pediatrics and Public Health at Johns Hopkins Medicine. The SpeeDx ResistancePlus MG test is in use in laboratories acr

Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults25.9.2018 13:00Pressemelding

First participants enrolled in Phase 2 clinical trial of quadrivalent NanoFlu formulations Top-line immunogenicity and safety data expected in the first quarter of 2019 Phase 2 results will support meeting with the U.S. Food and Drug Administration (FDA) and Phase 3 clinical trial design GAITHERSBURG, Md., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX) today announced the initiation of a Phase 2 dose and formulation confirmation clinical trial in older adults of NanoFlu, its nanoparticle seasonal influenza vaccine candidate. “Initiating this Phase 2 clinical trial of NanoFlu is an important milestone for Novavax,” said Stanley C. Erck, President and Chief Executive Officer of Novavax. “With top-line results expected in the first quarter of 2019, we plan to discuss these data with the FDA at an ‘End of Phase 2’ meeting and to agree on the appropriate Phase 3 clinical trial design to support licensure via accelerated approval. We continue to believe NanoFlu is a differen

CGAP Launches Photo and Video Contest Theme for 2018: Financial Inclusion in Africa25.9.2018 13:00Pressemelding

This year's CGAP contest is the first ever to accept short video entries WASHINGTON, Sept. 25, 2018 (GLOBE NEWSWIRE) -- The Consultative Group to Assist the Poor’s (CGAP) 13th annual photo contest, launched today, is seeking striking images on financial inclusion in Africa. For the first time, short video submissions on Africa also will be accepted. Entries may be submitted through December 14, 2018. Each contestant may submit up to 20 photos or videos to compete for the Grand Prize worth US$ 2,000. This year CGAP is looking for original and compelling photographs and short videos that tell the story of how financial services empower poor people and communities in Africa. The region is a center for financial innovation -- home to M-Pesa, the mobile money service launched a decade ago now replicated across markets worldwide; host to vibrant FinTech and e-commerce companies; and to a growing off-grid sector that leverages digital finance. Together these innovators contribute toward lifti

Kick-starting health in the workplace25.9.2018 10:00Pressemelding

Over 800 organizations step, bike, swim and yoga their way to better health and wellbeing as the May 2018 Virgin Pulse Global Challenge Concludes ZURICH, Switzerland, Sept. 25, 2018 (GLOBE NEWSWIRE) -- On August 30th more than 270,000 people, across 144 countries, completed Virgin Pulse’s 100-day Global Challenge, moving them towards a more active, healthy and productive lifestyle. With this achievement, Virgin Pulse, an international leader in employee health and wellbeing, once again proves it’s helping to improve employee lives for good. The company’s Global Challenge event encourages exercise, mindfulness and healthy habits at work, leading to a happier culture and reduced costs to the organization. “Through increased awareness, education and motivation, employees master long-term, sustainable habits allowing them to arrive at work feeling more engaged, productive and equipped for peak performance,” says David Osborne, Chief Executive Officer of Virgin Pulse. “The follow-on effects

GridGain Unveils Keynote Schedule for Fourth Annual In-Memory Computing Summit North America25.9.2018 09:00Pressemelding

Oracle Becomes Platinum Conference Sponsor FOSTER CITY, Calif., Sept. 25, 2018 (GLOBE NEWSWIRE) -- GridGain® Systems, provider of enterprise-grade in-memory computing solutions based on Apache® Ignite™, today announced the keynote speaker schedule for the fourth annual In-Memory Computing Summit® North America, taking place October 2-3, 2018 at the Hyatt Regency San Francisco Airport. Industry luminaries from ING Belgium, Wellington Management, Oracle, SNIA and GridGain Systems will discuss the evolution of in-memory computing technology and how organizations are leveraging in-memory computing to obtain the speed and scalability necessary for their digital transformation, omnichannel customer experience, Big Data and Fast Data initiatives. GridGain today also announced that Oracle has become a Platinum conference sponsor. The In-Memory Computing Summit North America 2018 is the only in-memory computing conference focusing on the full range of in-memory computing-related technologies an

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom